COMMUNIQUÉS West-GlobeNewswire

Rakovina Therapeutics Announces $1.5 Million Private Placement
15/07/2026
VANCOUVER, British Columbia, July 15, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)( FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)- [...]
MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026
15/07/2026
ROCKVILLE, Md., July 15, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and [...]
First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer
15/07/2026
First patients dosed in OPTIMAL-e 1 Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent’s Hospital Sydney. OPTIMAL-e will evaluate TLX597-Tx in earlier prostate cancer [...]
Sinopia Biosciences Publishes Preclinical Data in Science Translational Medicine Supporting SB-0110, a Novel PKA-II Modulator, for Parkinson's Disease
15/07/2026
Study in highly translatable non-human primate models demonstrate how selective PKA-II modulation in combination with levodopa improved motor benefit while reducing dyskinesia Development candidate, SB-0110, now [...]
RadioMedix Appoints Brian A. Markison to Board of Directors
15/07/2026
Leading pharmaceutical executive brings over 4 decades of commercial, M&A, and governance leadership HOUSTON, July 15, 2026 (GLOBE NEWSWIRE) -- RadioMedix, Inc., a clinical-stage biotechnology company focused on [...]
Rainwater Drake Dental Announces Name Change From Hawkins Rainwater Dental Group
15/07/2026
The West Little Rock practice retains its location, doctor team and range of dental services after more than 30 years in the community. Little Rock, AR, July 15, 2026 (GLOBE NEWSWIRE) -- Rainwater Drake Dental, a West [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2026
15/07/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 6th to 10th July 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total [...]
Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases
15/07/2026
CHICAGO, July 15, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased an [...]
At 68, Nutrition World Founder Edward Jones Returns to the Bodybuilding Stage and Challenges Assumptions About Aging
15/07/2026
CHATTANOOGA, Tenn., July 15, 2026 (GLOBE NEWSWIRE) -- Nutrition World founder Edward Jones , 68, returned to the bodybuilding stage at the Chattanooga Fitness Expo after overcoming years of chronic pain that once left [...]
Retrieve Medical Partners With Clear to Enhance Identity Verification For The Retrieve Medical Passport
15/07/2026
BEDMINSTER, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC Pink: RMHI) today announced a partnership with CLEAR, the secure identity company, to integrate CLEAR1, CLEAR's secure identity [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine xx - 2025
15/07/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 6 au 10 juillet 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Hyperion DeFi Enters Agreement with Skew Technologies to Launch HIP-3 Perpetual Futures Market and Listing Service
15/07/2026
Deployment of 500,000 HYPE Expands Client Service and Revenue Opportunities Positions Company as Bonded-Capital Layer for Institutional HIP-3 Listing Service Offering DALLAS, July 15, 2026 (GLOBE NEWSWIRE) -- Hyperion [...]
Rectify Pharmaceuticals Announces Appointment of Constantine Chinoporos as Executive Chairman
15/07/2026
The appointment comes as Rectify transitions into a clinical-stage company following the recent initiation of the Phase 1 study of RTY-406, its lead program for hepatobiliary diseases. Rectify is developing oral [...]
SBC Medical to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:30 a.m. ET
15/07/2026
IRVINE, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range [...]
Cynet Releases v4.33 Unveiling a New Cross-Site Dashboard and Enhanced SIEM Capabilities
15/07/2026
New enhancements deliver major advancements for IT and security teams to maximize scale, speed and interoperability of security environments BOSTON, July 15, 2026 (GLOBE NEWSWIRE) -- Cynet , the only unified, AI-powered [...]
Omada Health to Host its First Investor Day on September 10, 2026
15/07/2026
SAN FRANCISCO, July 15, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will host its first Investor Day on Thursday [...]
NewcelX Granted Patent in Brazil for NCEL-101 in Type 1 Diabetes, Expanding Global IP Portfolio
15/07/2026
Brazil patent complements U.S. patent portfolio for NCEL-101, strengthening global position in the type 1 diabetes market ZURICH, July 15, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (“NewcelX”; Nasdaq: NCEL), a clinical- [...]
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models
15/07/2026
Data show clade IIb from 2022 outbreak is 100 to 100,000-fold less virulent than clade IIa from 2003 outbreak Three new models for investigating mpox infection and pathogenesis identified Tonix is advancing TNX-801, a [...]
Alembic Therapeutics LLC Announces Exclusive U.S. Distribution of NUVESSA® (metronidazole vaginal gel 1.3%)
15/07/2026
BEDMINSTER, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics LLC today announced that it has become the exclusive U.S. distributor of NUVESSA® (metronidazole vaginal gel 1.3%), an FDA-approved prescription [...]

Pages